CALCIPOTRIENE

CALCIPOTRIENE was reported 3110 times

CALCIPOTRIENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYROGLOSSAL CYST INFECTION 4 0.5000
1 OTITIS EXTERNA FUNGAL 4 0.2500
2 ABSCESS SWEAT GLAND 5 0.1515
3 FEMALE SEX HORMONE LEVEL ABNORMAL 4 0.1176
4 PSORIASIS AREA SEVERITY INDEX INCREASED 5 0.0794
5 PENIS CARCINOMA 3 0.0789
6 BODY SURFACE AREA INCREASED 3 0.0714
7 INFECTED DERMAL CYST 16 0.0625
8 GALLBLADDER RUPTURE 9 0.0529
9 NEUROLOGIC NEGLECT SYNDROME 13 0.0451
10 CAROTID ARTERY THROMBOSIS 14 0.0264
11 ANTISYNTHETASE SYNDROME 2 0.0250
12 GENITAL ABSCESS 5 0.0231
13 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 2 0.0225
14 CYST RUPTURE 10 0.0216
15 ACQUIRED CLAW TOE 2 0.0213
16 WOUND INFECTION BACTERIAL 6 0.0209
17 GUTTATE PSORIASIS 11 0.0207
18 MENINGITIS STAPHYLOCOCCAL 2 0.0189
19 ILIAC ARTERY OCCLUSION 4 0.0186
20 MULTIPLE DRUG THERAPY 4 0.0185
21 ADJUSTMENT DISORDER 13 0.0149
22 BONE METABOLISM DISORDER 3 0.0133
23 MERALGIA PARAESTHETICA 2 0.0127
24 ECZEMA INFECTED 2 0.0125
25 GROIN ABSCESS 9 0.0122
26 ENDOMETRIAL DISORDER 4 0.0119
27 B PRECURSOR TYPE ACUTE LEUKAEMIA 2 0.0114
28 INFECTED CYST 9 0.0109
29 FALSE POSITIVE LABORATORY RESULT 2 0.0107
30 SCIATIC NERVE NEUROPATHY 4 0.0105
31 GROIN INFECTION 3 0.0086
32 SKIN PLAQUE 45 0.0086
33 MASTITIS 11 0.0082
34 SKIN HAEMORRHAGE 62 0.0080
35 PSORIASIS 688 0.0078
36 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 2 0.0073
37 ELBOW DEFORMITY 2 0.0072
38 PERSONALITY DISORDER 13 0.0064
39 STASIS DERMATITIS 3 0.0062
40 PSORIATIC ARTHROPATHY 122 0.0059
41 ENDOCARDITIS STAPHYLOCOCCAL 2 0.0057
42 INFECTED SKIN ULCER 8 0.0055
43 TESTICULAR SWELLING 5 0.0055
44 LARYNGEAL STENOSIS 2 0.0054
45 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 2 0.0051
46 SEBORRHOEIC DERMATITIS 5 0.0050
47 FACIAL ASYMMETRY 3 0.0047
48 HYDROCELE 4 0.0047
49 SECRETION DISCHARGE 34 0.0046
50 INFECTED BITE 2 0.0044
51 ATYPICAL PNEUMONIA 8 0.0044
52 PULMONARY CONGESTION 40 0.0042
53 SEBORRHOEIC KERATOSIS 4 0.0041
54 NODULAR REGENERATIVE HYPERPLASIA 2 0.0041
55 DERMATITIS PSORIASIFORM 5 0.0041
56 SKIN HYPERTROPHY 8 0.0041
57 BRONCHITIS VIRAL 2 0.0040
58 SKIN TEST POSITIVE 3 0.0040
59 INTESTINAL POLYP 5 0.0039
60 LIMB MASS 5 0.0039
61 CONJUNCTIVITIS ALLERGIC 3 0.0038
62 MAMMOGRAM ABNORMAL 2 0.0038
63 DACTYLITIS 2 0.0038
64 DIARRHOEA INFECTIOUS 2 0.0038
65 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0037
66 COMPLICATION OF PREGNANCY 2 0.0036
67 PULMONARY MASS 35 0.0036
68 VULVOVAGINAL CANDIDIASIS 3 0.0036
69 LUNG INFECTION PSEUDOMONAL 2 0.0036
70 DISCHARGE 2 0.0035
71 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0035
72 SINUS CONGESTION 33 0.0034
73 GENITAL BURNING SENSATION 2 0.0034
74 STOMA SITE HAEMORRHAGE 3 0.0033
75 LIMB ASYMMETRY 2 0.0032
76 NEURODERMATITIS 2 0.0032
77 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0031
78 RESPIRATORY TRACT CONGESTION 33 0.0031
79 SENSORY LOSS 18 0.0030
80 NAIL INFECTION 3 0.0030
81 THERAPEUTIC RESPONSE DELAYED 6 0.0030
82 GALLBLADDER ENLARGEMENT 2 0.0029
83 DEAFNESS TRANSITORY 2 0.0029
84 RENAL TUBULAR ACIDOSIS 4 0.0028
85 HAEMATOCRIT INCREASED 4 0.0027
86 CALCIPHYLAXIS 4 0.0027
87 LIPOMA 5 0.0027
88 NEPHROGENIC SYSTEMIC FIBROSIS 8 0.0027
89 OPEN WOUND 3 0.0027
90 COLITIS ISCHAEMIC 13 0.0026
91 PLANTAR FASCIITIS 6 0.0026
92 GLOSSITIS 7 0.0026
93 SKIN INDURATION 4 0.0026
94 BLADDER PROLAPSE 3 0.0026
95 SNEEZING 36 0.0026
96 LIPODYSTROPHY ACQUIRED 4 0.0025
97 PUSTULAR PSORIASIS 6 0.0025
98 AUDITORY DISORDER 2 0.0024
99 SINUS DISORDER 33 0.0024
100 CONCOMITANT DISEASE AGGRAVATED 11 0.0024
101 MYCOSIS FUNGOIDES 2 0.0024
102 TENDERNESS 18 0.0024
103 FAECES SOFT 8 0.0024
104 ACROCHORDON 2 0.0023
105 HEMIPLEGIA 15 0.0023
106 PERIPHERAL VENOUS DISEASE 3 0.0023
107 PERIPHERAL ARTERY OCCLUSION 2 0.0023
108 JOINT CONTRACTURE 2 0.0023
109 COCCYDYNIA 2 0.0022
110 FEAR OF INJECTION 8 0.0022
111 POLYARTHRITIS 7 0.0021
112 DERMATITIS CONTACT 16 0.0021
113 ACTINIC KERATOSIS 4 0.0021
114 LIP DISORDER 3 0.0021
115 HYPERKERATOSIS 8 0.0021
116 FORCED EXPIRATORY VOLUME DECREASED 4 0.0021
117 COLON ADENOMA 2 0.0020
118 CHEST X-RAY ABNORMAL 5 0.0020
119 SKIN FISSURES 18 0.0020
120 JOINT LOCK 4 0.0019
121 IMPETIGO 2 0.0019
122 MOTOR DYSFUNCTION 14 0.0019
123 MALIGNANT MELANOMA IN SITU 2 0.0019
124 SQUAMOUS CELL CARCINOMA 13 0.0019
125 ANTIPHOSPHOLIPID SYNDROME 2 0.0019
126 PHARYNGITIS STREPTOCOCCAL 13 0.0019
127 SKIN LACERATION 11 0.0019
128 BREAST MASS 9 0.0019
129 RECTAL CANCER 4 0.0018
130 LEFT ATRIAL DILATATION 2 0.0018
131 AFFECT LABILITY 14 0.0018
132 PROSTATOMEGALY 5 0.0018
133 ONYCHOCLASIS 8 0.0018
134 SPINAL STENOSIS 3 0.0018
135 PERIODONTAL DISEASE 2 0.0017
136 DEFAECATION URGENCY 6 0.0017
137 ECTOPIC PREGNANCY 4 0.0017
138 CERVICAL VERTEBRAL FRACTURE 4 0.0017
139 INJECTION SITE INFECTION 4 0.0016
140 GASTRITIS HAEMORRHAGIC 2 0.0016
141 GASTRIC DILATATION 2 0.0016
142 SKIN EXFOLIATION 89 0.0016
143 PATHOGEN RESISTANCE 9 0.0016
144 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0016
145 THERAPEUTIC RESPONSE SHORTENED 14 0.0016
146 MACULE 3 0.0016
147 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
148 DIABETIC FOOT INFECTION 2 0.0016
149 RHINORRHOEA 65 0.0016
150 PAIN OF SKIN 32 0.0016
151 FURUNCLE 9 0.0016
152 LYMPHADENOPATHY MEDIASTINAL 2 0.0016
153 HOMICIDE 2 0.0016
154 ANAL HAEMORRHAGE 3 0.0015
155 LYMPH NODE PAIN 2 0.0015
156 CHORIORETINOPATHY 2 0.0015
157 PAPULE 6 0.0015
158 MOVEMENT DISORDER 35 0.0015
159 HYPERPHAGIA 4 0.0015
160 ASPHYXIA 8 0.0015
161 EYELID MARGIN CRUSTING 2 0.0015
162 UTERINE LEIOMYOMA 8 0.0014
163 CYSTITIS 34 0.0014
164 SKIN WARM 6 0.0014
165 PRODUCT PRESCRIBING ERROR 15 0.0014
166 PLASMACYTOMA 2 0.0014
167 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0014
168 LARYNGOSPASM 3 0.0014
169 COLONOSCOPY 2 0.0014
170 MUCOSAL DRYNESS 2 0.0014
171 GRIP STRENGTH DECREASED 6 0.0014
172 TOOTH INFECTION 12 0.0014
173 OSTEOMYELITIS 19 0.0013
174 NASAL DISCOMFORT 8 0.0013
175 MUSCLE SPASTICITY 13 0.0013
176 BOWEL MOVEMENT IRREGULARITY 6 0.0013
177 TUBERCULIN TEST POSITIVE 3 0.0013
178 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0013
179 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0013
180 WOUND SECRETION 4 0.0013
181 COORDINATION ABNORMAL 15 0.0013
182 EXERCISE TOLERANCE DECREASED 5 0.0013
183 VITAMIN D DECREASED 8 0.0013
184 SKIN ATROPHY 5 0.0013
185 CYST 11 0.0013
186 ORAL CANDIDIASIS 11 0.0013
187 NEPHROGENIC ANAEMIA 5 0.0013
188 IMMUNE SYSTEM DISORDER 11 0.0013
189 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0012
190 CHANGE OF BOWEL HABIT 2 0.0012
191 LIGAMENT SPRAIN 8 0.0012
192 BACTERIAL TEST POSITIVE 2 0.0012
193 CERVICAL DYSPLASIA 2 0.0012
194 PULMONARY TUBERCULOSIS 4 0.0012
195 RALES 5 0.0012
196 HEMIPARESIS 16 0.0012
197 UMBILICAL HERNIA 4 0.0012
198 FREQUENT BOWEL MOVEMENTS 18 0.0012
199 INGROWING NAIL 2 0.0012
200 ORAL PAIN 19 0.0012
201 GASTRIC INFECTION 3 0.0012
202 POST PROCEDURAL INFECTION 6 0.0012
203 CD4 LYMPHOCYTES DECREASED 2 0.0012
204 ANIMAL BITE 2 0.0012
205 DYSLIPIDAEMIA 4 0.0012
206 PANIC ATTACK 31 0.0012
207 TOOTH ABSCESS 9 0.0011
208 NASAL DRYNESS 5 0.0011
209 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0011
210 SKIN TIGHTNESS 4 0.0011
211 ECZEMA 20 0.0011
212 NASOPHARYNGITIS 133 0.0011
213 STREPTOCOCCAL INFECTION 4 0.0011
214 BASAL CELL CARCINOMA 12 0.0011
215 NON-CARDIAC CHEST PAIN 3 0.0011
216 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0011
217 UPPER RESPIRATORY TRACT INFECTION 35 0.0011
218 DECREASED IMMUNE RESPONSIVENESS 6 0.0011
219 LIP DRY 5 0.0011
220 EAR CONGESTION 2 0.0011
221 STAPHYLOCOCCAL BACTERAEMIA 3 0.0011
222 DENTAL CARIES 9 0.0011
223 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0011
224 COLITIS 25 0.0011
225 CARTILAGE INJURY 2 0.0011
226 RENAL FUNCTION TEST ABNORMAL 3 0.0011
227 DERMATITIS 14 0.0011
228 BILIARY COLIC 2 0.0011
229 HIDRADENITIS 3 0.0011
230 PLATELET COUNT ABNORMAL 4 0.0011
231 EPIGASTRIC DISCOMFORT 3 0.0011
232 APHTHOUS ULCER 4 0.0011
233 SKIN PAPILLOMA 3 0.0011
234 CAROTID ARTERY STENOSIS 3 0.0011
235 SPINAL PAIN 8 0.0010
236 HYPERLIPIDAEMIA 10 0.0010
237 INCONTINENCE 8 0.0010
238 HYPERCALCAEMIA 9 0.0010
239 SUNBURN 6 0.0010
240 SKIN DISCOLOURATION 34 0.0010
241 OPTIC NEURITIS 7 0.0010
242 PHOTOSENSITIVITY REACTION 12 0.0010
243 BACTERIAL INFECTION 12 0.0010
244 ALCOHOL POISONING 2 0.0010
245 CELLULITIS 37 0.0010
246 PARANASAL SINUS HYPERSECRETION 3 0.0010
247 STRESS 47 0.0010
248 BONE MARROW DISORDER 2 0.0010
249 BLOOD URINE PRESENT 14 0.0010
250 PHARYNGITIS 9 0.0010
251 LABYRINTHITIS 2 0.0010
252 ANKYLOSING SPONDYLITIS 6 0.0010
253 HEART VALVE INCOMPETENCE 2 0.0010
254 PIGMENTATION DISORDER 4 0.0010
255 NASAL CONGESTION 35 0.0010
256 SLEEP APNOEA SYNDROME 14 0.0010
257 LOWER RESPIRATORY TRACT INFECTION 27 0.0010
258 HYPERPARATHYROIDISM SECONDARY 2 0.0010
259 BURNING SENSATION 49 0.0010
260 ARTHRITIS INFECTIVE 3 0.0010
261 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0009
262 INFLUENZA 67 0.0009
263 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0009
264 METABOLIC ENCEPHALOPATHY 2 0.0009
265 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0009
266 DRUG ERUPTION 11 0.0009
267 NERVE COMPRESSION 6 0.0009
268 WRIST FRACTURE 8 0.0009
269 BLOOD CHLORIDE DECREASED 2 0.0009
270 EATING DISORDER 14 0.0009
271 ANHEDONIA 19 0.0009
272 NEPHRITIS 2 0.0009
273 DYSAESTHESIA 2 0.0009
274 PAPILLOEDEMA 3 0.0009
275 MENINGIOMA 2 0.0009
276 ECONOMIC PROBLEM 13 0.0009
277 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0009
278 POSTOPERATIVE WOUND INFECTION 4 0.0009
279 SPINAL OSTEOARTHRITIS 6 0.0009
280 NEPHROLITHIASIS 27 0.0009
281 PROCTALGIA 4 0.0009
282 MIGRAINE 55 0.0009
283 SCRATCH 5 0.0009
284 SINUSITIS 61 0.0009
285 BACK INJURY 6 0.0009
286 THERAPY PARTIAL RESPONDER 3 0.0009
287 SKIN DISORDER 18 0.0009
288 MONOCYTE COUNT INCREASED 2 0.0008
289 SKIN INFECTION 6 0.0008
290 BURSITIS 6 0.0008
291 TONGUE DISCOLOURATION 3 0.0008
292 STAPHYLOCOCCAL INFECTION 21 0.0008
293 MENSTRUATION DELAYED 7 0.0008
294 HEPATIC NEOPLASM 2 0.0008
295 FEMORAL NECK FRACTURE 3 0.0008
296 SLEEP DISORDER 36 0.0008
297 DISCOMFORT 28 0.0008
298 RASH PUSTULAR 5 0.0008
299 THERAPY NON-RESPONDER 18 0.0008
300 RENAL CELL CARCINOMA 3 0.0008
301 LARGE INTESTINE POLYP 4 0.0008
302 VARICOSE VEIN 3 0.0008
303 FOOT DEFORMITY 6 0.0008
304 EXOSTOSIS 5 0.0008
305 WOUND 12 0.0008
306 HELICOBACTER INFECTION 3 0.0008
307 LOCALISED INFECTION 13 0.0008
308 HAEMOGLOBIN INCREASED 2 0.0008
309 MOUTH HAEMORRHAGE 4 0.0008
310 ACCIDENT 6 0.0008
311 IRON DEFICIENCY 2 0.0008
312 INFLAMMATORY MARKER INCREASED 2 0.0008
313 NEUROLOGICAL SYMPTOM 3 0.0008
314 CAROTID ARTERY OCCLUSION 2 0.0008
315 PRURITUS 172 0.0008
316 APHASIA 17 0.0008
317 THERMAL BURN 4 0.0008
318 BLOOD PRESSURE INADEQUATELY CONTROLLED 4 0.0008
319 LIMB OPERATION 2 0.0008
320 CANDIDIASIS 3 0.0007
321 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0007
322 THERAPEUTIC RESPONSE DECREASED 30 0.0007
323 EAR INFECTION 12 0.0007
324 BLISTER 27 0.0007
325 NAIL DISCOLOURATION 2 0.0007
326 QUALITY OF LIFE DECREASED 7 0.0007
327 CORONARY ARTERY STENOSIS 3 0.0007
328 ILL-DEFINED DISORDER 20 0.0007
329 OROPHARYNGEAL PAIN 44 0.0007
330 SKIN LESION 13 0.0007
331 GENERALISED OEDEMA 6 0.0007
332 PRODUCT PRESCRIBING ISSUE 3 0.0007
333 LACRIMATION INCREASED 13 0.0007
334 SPLENOMEGALY 6 0.0007
335 GASTROINTESTINAL PAIN 5 0.0007
336 VISUAL FIELD DEFECT 4 0.0007
337 TOOTHACHE 9 0.0007
338 C-REACTIVE PROTEIN ABNORMAL 2 0.0007
339 ARTHRITIS BACTERIAL 2 0.0007
340 BIPOLAR DISORDER 6 0.0007
341 NODULE 6 0.0007
342 RENAL PAIN 5 0.0007
343 ORGANISING PNEUMONIA 2 0.0007
344 INGUINAL HERNIA 3 0.0007
345 POLYNEUROPATHY 5 0.0007
346 SUBARACHNOID HAEMORRHAGE 5 0.0007
347 DEAFNESS 12 0.0007
348 GINGIVAL DISORDER 2 0.0007
349 PRODUCT DOSE OMISSION 45 0.0007
350 LYMPHOEDEMA 3 0.0007
351 BODY HEIGHT DECREASED 6 0.0007
352 OSTEOPENIA 7 0.0007
353 CONJUNCTIVITIS 7 0.0007
354 DERMATITIS EXFOLIATIVE 3 0.0007
355 RENAL CYST 4 0.0007
356 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0007
357 MELANOCYTIC NAEVUS 2 0.0007
358 JOINT STIFFNESS 12 0.0007
359 ENCEPHALITIS 3 0.0007
360 CREATININE RENAL CLEARANCE DECREASED 2 0.0007
361 CHRONIC KIDNEY DISEASE 41 0.0007
362 PRODUCT DISPENSING ERROR 6 0.0007
363 PERIPHERAL ISCHAEMIA 2 0.0007
364 INFLUENZA LIKE ILLNESS 42 0.0007
365 EYE DISCHARGE 4 0.0007
366 MUSCLE STRAIN 4 0.0007
367 FINGER DEFORMITY 2 0.0006
368 DIVERTICULUM INTESTINAL 2 0.0006
369 ANAPHYLACTOID REACTION 2 0.0006
370 WOUND INFECTION 4 0.0006
371 HEPATIC CIRRHOSIS 8 0.0006
372 POOR QUALITY SLEEP 9 0.0006
373 IMMOBILE 2 0.0006
374 OVARIAN CYST 5 0.0006
375 SCIATICA 6 0.0006
376 MUSCULOSKELETAL STIFFNESS 37 0.0006
377 HEPATIC FUNCTION ABNORMAL 15 0.0006
378 PERIPHERAL SWELLING 59 0.0006
379 MALIGNANT MELANOMA 6 0.0006
380 LEFT VENTRICULAR HYPERTROPHY 2 0.0006
381 SKIN HYPERPIGMENTATION 4 0.0006
382 SKIN IRRITATION 22 0.0006
383 NEEDLE ISSUE 8 0.0006
384 FUNGAL INFECTION 14 0.0006
385 PRODUCT DOSE OMISSION ISSUE 36 0.0006
386 INJECTION SITE BRUISING 32 0.0006
387 TEMPERATURE INTOLERANCE 4 0.0006
388 DRY EYE 15 0.0006
389 OCULAR ICTERUS 2 0.0006
390 ABNORMAL LOSS OF WEIGHT 3 0.0006
391 HORMONE LEVEL ABNORMAL 2 0.0006
392 ARTHROPOD BITE 3 0.0006
393 UPPER-AIRWAY COUGH SYNDROME 3 0.0006
394 LIP SWELLING 14 0.0006
395 INFLAMMATION 18 0.0006
396 ILLNESS 11 0.0006
397 CARDIOMEGALY 6 0.0006
398 APPLICATION SITE PAIN 10 0.0006
399 LIMB DISCOMFORT 12 0.0006
400 RASH PAPULAR 10 0.0006
401 DRUG EFFECT INCOMPLETE 21 0.0006
402 PRODUCTIVE COUGH 17 0.0006
403 CONTUSION 38 0.0006
404 DIARRHOEA 242 0.0006
405 NAIL DISORDER 3 0.0006
406 DYSARTHRIA 16 0.0006
407 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0006
408 ARTHRITIS 30 0.0006
409 RASH MACULAR 13 0.0006
410 COLECTOMY 2 0.0006
411 CHEST PAIN 78 0.0006
412 LARYNGITIS 4 0.0006
413 GOUT 7 0.0006
414 NEPHROPATHY 4 0.0006
415 HOMICIDAL IDEATION 2 0.0006
416 FACIAL PARALYSIS 3 0.0006
417 BLOOD CHOLESTEROL INCREASED 18 0.0006
418 HYPERSOMNIA 11 0.0005
419 ISCHAEMIA 2 0.0005
420 INTERVERTEBRAL DISC DEGENERATION 4 0.0005
421 UVEITIS 4 0.0005
422 EOSINOPHIL COUNT INCREASED 3 0.0005
423 COUGH 98 0.0005
424 PATHOLOGICAL FRACTURE 2 0.0005
425 ANKLE FRACTURE 6 0.0005
426 BUNDLE BRANCH BLOCK RIGHT 2 0.0005
427 INJECTION SITE IRRITATION 5 0.0005
428 HAND DEFORMITY 3 0.0005
429 SPINAL OPERATION 3 0.0005
430 LACERATION 5 0.0005
431 ULCER 6 0.0005
432 JOINT RANGE OF MOTION DECREASED 4 0.0005
433 END STAGE RENAL DISEASE 8 0.0005
434 CORONARY ARTERY OCCLUSION 6 0.0005
435 APPLICATION SITE VESICLES 3 0.0005
436 GINGIVAL PAIN 3 0.0005
437 DERMATITIS ATOPIC 4 0.0005
438 BLOOD URIC ACID INCREASED 2 0.0005
439 SEASONAL ALLERGY 4 0.0005
440 BRONCHITIS 29 0.0005
441 RESPIRATORY DISORDER 11 0.0005
442 WHITE BLOOD CELL COUNT INCREASED 15 0.0005
443 ERYTHEMA 76 0.0005
444 TONGUE DISORDER 3 0.0005
445 LUPUS-LIKE SYNDROME 3 0.0005
446 WEIGHT FLUCTUATION 3 0.0005
447 HYPERCHOLESTEROLAEMIA 3 0.0005
448 IRRITABILITY 24 0.0005
449 UTERINE CANCER 3 0.0005
450 PAIN IN EXTREMITY 109 0.0005
451 GINGIVITIS 2 0.0005
452 INTRACRANIAL PRESSURE INCREASED 2 0.0005
453 MACULAR OEDEMA 2 0.0005
454 PULMONARY HYPERTENSION 8 0.0005
455 DRUG EFFECT DECREASED 27 0.0005
456 MULTIPLE INJURIES 3 0.0005
457 ODYNOPHAGIA 2 0.0005
458 LOWER LIMB FRACTURE 6 0.0005
459 MALAISE 160 0.0005
460 CANDIDA INFECTION 5 0.0005
461 INFECTION 45 0.0005
462 CORONARY ARTERY DISEASE 13 0.0005
463 HERPES VIRUS INFECTION 2 0.0005
464 PAIN 194 0.0005
465 SKIN ULCER 9 0.0005
466 HEADACHE 215 0.0005
467 LYMPHADENOPATHY 12 0.0005
468 THYROID CANCER 4 0.0005
469 MUSCULOSKELETAL PAIN 22 0.0005
470 INTERVERTEBRAL DISC PROTRUSION 8 0.0005
471 MUSCLE ATROPHY 4 0.0005
472 INJECTION SITE WARMTH 8 0.0005
473 SUICIDAL IDEATION 33 0.0005
474 INJECTION SITE REACTION 24 0.0005
475 GASTROINTESTINAL CARCINOMA 3 0.0005
476 PNEUMONIA 105 0.0005
477 SPUTUM DISCOLOURED 3 0.0005
478 THROAT IRRITATION 14 0.0005
479 CEREBRAL ISCHAEMIA 2 0.0005
480 APPLICATION SITE REACTION 3 0.0005
481 MENISCUS INJURY 2 0.0005
482 ANORECTAL DISCOMFORT 2 0.0005
483 INJECTION SITE URTICARIA 7 0.0005
484 ROAD TRAFFIC ACCIDENT 14 0.0005
485 LYMPHOMA 5 0.0005
486 INJECTION SITE PAIN 88 0.0005
487 DECREASED ACTIVITY 3 0.0005
488 FEELING OF BODY TEMPERATURE CHANGE 2 0.0005
489 IMPAIRED HEALING 10 0.0005
490 PERIPHERAL VASCULAR DISORDER 2 0.0005
491 BLOOD CALCIUM INCREASED 3 0.0005
492 JOINT SWELLING 35 0.0005
493 BLOOD CREATININE INCREASED 22 0.0005
494 PLATELET COUNT INCREASED 4 0.0005
495 HIP ARTHROPLASTY 4 0.0005
496 DIARRHOEA HAEMORRHAGIC 3 0.0005
497 ABDOMINAL PAIN UPPER 64 0.0005
498 AUTOIMMUNE DISORDER 2 0.0004
499 INCREASED UPPER AIRWAY SECRETION 2 0.0004
500 RASH 127 0.0004
501 HALLUCINATION, AUDITORY 5 0.0004
502 CONDITION AGGRAVATED 78 0.0004
503 GAIT INABILITY 7 0.0004
504 HAEMATOCRIT DECREASED 7 0.0004
505 HEPATIC ENZYME INCREASED 19 0.0004
506 NEURALGIA 7 0.0004
507 ORAL MUCOSAL BLISTERING 2 0.0004
508 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0004
509 ARTHROPATHY 16 0.0004
510 ERYTHEMA MULTIFORME 3 0.0004
511 BLOOD TRIGLYCERIDES INCREASED 6 0.0004
512 URINARY TRACT INFECTION 49 0.0004
513 WHEEZING 16 0.0004
514 FRUSTRATION TOLERANCE DECREASED 2 0.0004
515 DEFORMITY 3 0.0004
516 NERVOUSNESS 18 0.0004
517 ADVERSE DRUG REACTION 22 0.0004
518 OLIGURIA 2 0.0004
519 ABORTION SPONTANEOUS 13 0.0004
520 ARTERIOSCLEROSIS 3 0.0004
521 HYPOPHOSPHATAEMIA 2 0.0004
522 CARDIAC MURMUR 3 0.0004
523 PERICARDITIS 3 0.0004
524 FAECAL INCONTINENCE 2 0.0004
525 CORONARY ARTERY BYPASS 2 0.0004
526 SEPTIC SHOCK 12 0.0004
527 JOINT DISLOCATION 3 0.0004
528 ROTATOR CUFF SYNDROME 4 0.0004
529 OSTEOARTHRITIS 12 0.0004
530 INJECTION SITE ERYTHEMA 37 0.0004
531 HAND FRACTURE 2 0.0004
532 EMOTIONAL DISTRESS 27 0.0004
533 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0004
534 NO THERAPEUTIC RESPONSE 5 0.0004
535 ABDOMINAL DISCOMFORT 45 0.0004
536 METRORRHAGIA 7 0.0004
537 ARTHRALGIA 108 0.0004
538 TYPE 2 DIABETES MELLITUS 10 0.0004
539 NAUSEA 224 0.0004
540 FULL BLOOD COUNT DECREASED 5 0.0004
541 ASPIRATION 3 0.0004
542 PYREXIA 98 0.0004
543 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0004
544 BACTERAEMIA 3 0.0004
545 GASTROINTESTINAL INFLAMMATION 2 0.0004
546 MALNUTRITION 3 0.0004
547 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0004
548 LUNG INFILTRATION 3 0.0004
549 IMMUNOSUPPRESSION 2 0.0004
550 HOSPICE CARE 2 0.0004
551 INJECTION SITE HAEMORRHAGE 20 0.0004
552 RENAL FAILURE CHRONIC 3 0.0004
553 RASH PRURITIC 14 0.0004
554 SCAB 3 0.0004
555 INCORRECT DOSE ADMINISTERED 44 0.0004
556 CONCUSSION 2 0.0004
557 KNEE OPERATION 2 0.0004
558 RASH ERYTHEMATOUS 11 0.0004
559 DYSPHAGIA 25 0.0004
560 WEIGHT DECREASED 73 0.0004
561 IMMUNODEFICIENCY 3 0.0004
562 PHARYNGOLARYNGEAL PAIN 2 0.0004
563 HYDRONEPHROSIS 2 0.0004
564 EMBEDDED DEVICE 2 0.0004
565 HERPES ZOSTER 15 0.0004
566 TOOTH FRACTURE 3 0.0004
567 SEXUAL DYSFUNCTION 3 0.0004
568 MUSCULOSKELETAL CHEST PAIN 4 0.0004
569 MYALGIA 45 0.0004
570 LIVER FUNCTION TEST ABNORMAL 9 0.0004
571 DIABETES MELLITUS 21 0.0004
572 DRUG INEFFECTIVE 323 0.0004
573 DEPRESSED MOOD 13 0.0004
574 HYPERKALAEMIA 9 0.0004
575 OEDEMA PERIPHERAL 35 0.0004
576 ANXIETY 75 0.0004
577 APPLICATION SITE ERYTHEMA 8 0.0004
578 FORMICATION 2 0.0004
579 MOUTH ULCERATION 5 0.0004
580 GALLBLADDER DISORDER 5 0.0004
581 FLATULENCE 14 0.0004
582 DEVICE MALFUNCTION 13 0.0004
583 BLOOD MAGNESIUM DECREASED 2 0.0004
584 ERUCTATION 4 0.0004
585 MITRAL VALVE INCOMPETENCE 3 0.0003
586 HAEMORRHOIDS 5 0.0003
587 INJECTION SITE DISCOLOURATION 3 0.0003
588 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
589 JOINT INJURY 5 0.0003
590 C-REACTIVE PROTEIN INCREASED 8 0.0003
591 HYSTERECTOMY 2 0.0003
592 HEREDITARY ANGIOEDEMA 2 0.0003
593 DEPRESSION 60 0.0003
594 INCREASED APPETITE 4 0.0003
595 DYSPNOEA 136 0.0003
596 MUSCULOSKELETAL DISCOMFORT 4 0.0003
597 GASTROENTERITIS VIRAL 4 0.0003
598 CATARACT 13 0.0003
599 BLOOD ALBUMIN DECREASED 2 0.0003
600 HOT FLUSH 16 0.0003
601 RENAL DISORDER 11 0.0003
602 RETCHING 5 0.0003
603 DRUG ABUSER 2 0.0003
604 GAIT DISTURBANCE 46 0.0003
605 FACIAL PAIN 2 0.0003
606 AORTIC ANEURYSM 2 0.0003
607 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0003
608 NECK PAIN 13 0.0003
609 PROCEDURAL PAIN 6 0.0003
610 HYPERTENSION 48 0.0003
611 DECUBITUS ULCER 2 0.0003
612 GINGIVAL BLEEDING 3 0.0003
613 HYPOAESTHESIA 35 0.0003
614 PAIN IN JAW 7 0.0003
615 MYDRIASIS 3 0.0003
616 HEART RATE INCREASED 22 0.0003
617 SUICIDE ATTEMPT 14 0.0003
618 MOBILITY DECREASED 15 0.0003
619 DIVERTICULITIS 6 0.0003
620 CONGENITAL ANOMALY 2 0.0003
621 INJECTION SITE RASH 6 0.0003
622 GLOSSODYNIA 4 0.0003
623 WEIGHT INCREASED 48 0.0003
624 ADRENAL INSUFFICIENCY 2 0.0003
625 HYPERAESTHESIA 2 0.0003
626 VOMITING 102 0.0003
627 DRUG SCREEN POSITIVE 2 0.0003
628 FAECES DISCOLOURED 5 0.0003
629 LEUKOCYTOSIS 4 0.0003
630 RENAL CANCER 11 0.0003
631 PARAESTHESIA ORAL 3 0.0003
632 HYPOACUSIS 8 0.0003
633 POLLAKIURIA 9 0.0003
634 IRON DEFICIENCY ANAEMIA 2 0.0003
635 NIGHTMARE 8 0.0003
636 INJECTION SITE SWELLING 15 0.0003
637 EYE HAEMORRHAGE 3 0.0003
638 DRY MOUTH 17 0.0003
639 RESPIRATORY TRACT INFECTION 5 0.0003
640 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0003
641 IMPAIRED QUALITY OF LIFE 2 0.0003
642 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0003
643 FLANK PAIN 2 0.0003
644 LIVER DISORDER 9 0.0003
645 EAR PAIN 4 0.0003
646 SWELLING FACE 14 0.0003
647 INJECTION SITE HAEMATOMA 4 0.0003
648 PARAESTHESIA 34 0.0003
649 DRUG DOSE OMISSION 49 0.0003
650 DRY SKIN 25 0.0003
651 MUSCULAR WEAKNESS 24 0.0003
652 SWELLING 18 0.0003
653 INITIAL INSOMNIA 2 0.0003
654 GENERALISED TONIC-CLONIC SEIZURE 3 0.0003
655 PREGNANCY 5 0.0003
656 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0003
657 DEVICE ISSUE 14 0.0003
658 HAEMORRHAGE 21 0.0003
659 BLOOD UREA INCREASED 4 0.0003
660 BREAST CANCER 21 0.0003
661 SKIN BURNING SENSATION 16 0.0003
662 HAEMATOCHEZIA 10 0.0003
663 PRODUCT STORAGE ERROR 8 0.0003
664 BACK PAIN 48 0.0003
665 FATIGUE 150 0.0003
666 GLAUCOMA 4 0.0003
667 COLON CANCER 3 0.0003
668 BLOOD BILIRUBIN INCREASED 6 0.0003
669 CHEST DISCOMFORT 20 0.0003
670 LOCAL SWELLING 5 0.0003
671 STEVENS-JOHNSON SYNDROME 5 0.0003
672 BRAIN INJURY 2 0.0003
673 DYSSTASIA 6 0.0003
674 INCREASED TENDENCY TO BRUISE 2 0.0003
675 FALL 67 0.0003
676 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
677 GASTROENTERITIS 3 0.0003
678 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0003
679 CHOLELITHIASIS 7 0.0003
680 DRUG INTOLERANCE 17 0.0003
681 MENTAL IMPAIRMENT 5 0.0003
682 ALOPECIA 40 0.0003
683 AMNESIA 14 0.0003
684 ABSCESS 3 0.0003
685 PNEUMOTHORAX 3 0.0003
686 RIB FRACTURE 4 0.0003
687 POST PROCEDURAL COMPLICATION 4 0.0003
688 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
689 VISUAL ACUITY REDUCED 8 0.0003
690 NEOPLASM MALIGNANT 12 0.0003
691 HYPOAESTHESIA ORAL 3 0.0003
692 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
693 VIRAL INFECTION 6 0.0003
694 OSTEOPOROSIS 8 0.0003
695 RENAL FAILURE 29 0.0003
696 RASH GENERALISED 7 0.0003
697 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0003
698 TREATMENT NONCOMPLIANCE 9 0.0003
699 ACUTE KIDNEY INJURY 26 0.0003
700 UPPER LIMB FRACTURE 4 0.0003
701 CENTRAL NERVOUS SYSTEM LESION 3 0.0003
702 DYSPEPSIA 18 0.0003
703 NEUTROPHIL COUNT INCREASED 2 0.0003
704 ATELECTASIS 2 0.0003
705 TRANSIENT ISCHAEMIC ATTACK 7 0.0003
706 TOOTH LOSS 4 0.0003
707 HYPERHIDROSIS 25 0.0003
708 SEPSIS 21 0.0003
709 DYSGEUSIA 14 0.0003
710 INFLAMMATORY BOWEL DISEASE 2 0.0003
711 BACK DISORDER 3 0.0003
712 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0003
713 LEUKOPENIA 9 0.0003
714 METASTASES TO LIVER 3 0.0003
715 CEREBROVASCULAR ACCIDENT 34 0.0003
716 MACULAR DEGENERATION 2 0.0003
717 KNEE ARTHROPLASTY 3 0.0003
718 RENAL IMPAIRMENT 14 0.0003
719 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
720 STOMATITIS 10 0.0003
721 BLOOD POTASSIUM INCREASED 3 0.0003
722 MICTURITION URGENCY 2 0.0003
723 DERMATITIS ALLERGIC 2 0.0003
724 INJECTION SITE MASS 6 0.0003
725 NOCTURIA 2 0.0003
726 HYPOXIA 6 0.0002
727 ASTHENIA 66 0.0002
728 LIVER FUNCTION TEST INCREASED 3 0.0002
729 URTICARIA 28 0.0002
730 HEPATIC CANCER 4 0.0002
731 ORAL HERPES 3 0.0002
732 PULMONARY FIBROSIS 3 0.0002
733 ABDOMINAL PAIN 40 0.0002
734 PLEURAL EFFUSION 11 0.0002
735 CONFUSIONAL STATE 29 0.0002
736 BLOOD PRESSURE INCREASED 26 0.0002
737 CHILLS 20 0.0002
738 NERVE INJURY 2 0.0002
739 THROMBOSIS 14 0.0002
740 HAEMOGLOBIN DECREASED 18 0.0002
741 IRRITABLE BOWEL SYNDROME 3 0.0002
742 INSOMNIA 47 0.0002
743 OEDEMA 9 0.0002
744 BLOOD TEST ABNORMAL 2 0.0002
745 MEMORY IMPAIRMENT 23 0.0002
746 ABDOMINAL DISTENSION 17 0.0002
747 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
748 HERNIA 3 0.0002
749 NERVOUS SYSTEM DISORDER 6 0.0002
750 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
751 MIDDLE INSOMNIA 3 0.0002
752 SCAR 3 0.0002
753 MUSCLE TWITCHING 4 0.0002
754 EYE SWELLING 6 0.0002
755 VISION BLURRED 22 0.0002
756 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
757 MULTIPLE SCLEROSIS 8 0.0002
758 CHOLECYSTITIS 2 0.0002
759 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
760 HEAD INJURY 5 0.0002
761 IMPAIRED DRIVING ABILITY 2 0.0002
762 SPINAL FRACTURE 3 0.0002
763 KIDNEY INFECTION 3 0.0002
764 DEEP VEIN THROMBOSIS 12 0.0002
765 HYPERSENSITIVITY 29 0.0002
766 MEDICATION ERROR 9 0.0002
767 ANGINA PECTORIS 5 0.0002
768 CARDIOGENIC SHOCK 2 0.0002
769 PALLOR 4 0.0002
770 INTERSTITIAL LUNG DISEASE 7 0.0002
771 EPISTAXIS 12 0.0002
772 LYMPHOPENIA 2 0.0002
773 COGNITIVE DISORDER 7 0.0002
774 TREATMENT FAILURE 11 0.0002
775 HYPOGLYCAEMIA 8 0.0002
776 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
777 UNRESPONSIVE TO STIMULI 4 0.0002
778 INJECTION SITE PRURITUS 10 0.0002
779 ABDOMINAL PAIN LOWER 4 0.0002
780 BEDRIDDEN 2 0.0002
781 LIBIDO DECREASED 2 0.0002
782 MUSCLE SPASMS 28 0.0002
783 COVID-19 7 0.0002
784 PANCYTOPENIA 8 0.0002
785 RED BLOOD CELL COUNT DECREASED 4 0.0002
786 SPEECH DISORDER 8 0.0002
787 APPLICATION SITE IRRITATION 2 0.0002
788 SURGERY 7 0.0002
789 BALANCE DISORDER 13 0.0002
790 INTESTINAL OBSTRUCTION 5 0.0002
791 DECREASED APPETITE 31 0.0002
792 CARPAL TUNNEL SYNDROME 2 0.0002
793 ABASIA 5 0.0002
794 THINKING ABNORMAL 3 0.0002
795 DYSPHONIA 8 0.0002
796 NEUROPATHY PERIPHERAL 12 0.0002
797 LOSS OF CONSCIOUSNESS 19 0.0002
798 PHARYNGEAL OEDEMA 3 0.0002
799 CONSTIPATION 28 0.0002
800 GASTRIC DISORDER 6 0.0002
801 GENITAL HAEMORRHAGE 2 0.0002
802 INJECTION SITE INDURATION 2 0.0002
803 HIATUS HERNIA 2 0.0002
804 HYPOTHYROIDISM 4 0.0002
805 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
806 FIBROMYALGIA 3 0.0002
807 WHITE BLOOD CELL COUNT DECREASED 14 0.0002
808 MASS 2 0.0002
809 HAIR COLOUR CHANGES 2 0.0002
810 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0002
811 DISORIENTATION 6 0.0002
812 LUNG INFECTION 3 0.0002
813 PERICARDIAL EFFUSION 3 0.0002
814 BLOOD PRESSURE DECREASED 9 0.0002
815 HAEMOPTYSIS 4 0.0002
816 OBESITY 2 0.0002
817 PARALYSIS 2 0.0002
818 FLUID RETENTION 7 0.0002
819 FEELING ABNORMAL 34 0.0002
820 HAEMATURIA 5 0.0002
821 DEVICE DIFFICULT TO USE 3 0.0002
822 ANAEMIA 26 0.0002
823 INFUSION RELATED REACTION 7 0.0002
824 HEPATITIS C 2 0.0002
825 CARDIAC DISORDER 13 0.0002
826 CEREBRAL HAEMORRHAGE 5 0.0002
827 ANGER 5 0.0002
828 RECTAL HAEMORRHAGE 6 0.0002
829 GASTRIC CANCER 3 0.0002
830 PRURITUS GENERALISED 4 0.0002
831 URINARY INCONTINENCE 4 0.0002
832 DYSURIA 5 0.0002
833 TINNITUS 6 0.0002
834 DIZZINESS 64 0.0002
835 GASTROINTESTINAL DISORDER 9 0.0002
836 MELAENA 3 0.0002
837 PRESYNCOPE 3 0.0002
838 VERTIGO 8 0.0002
839 HYPOTENSION 25 0.0002
840 BONE LOSS 2 0.0002
841 CHROMATURIA 3 0.0002
842 UNEVALUABLE EVENT 10 0.0002
843 BREAST CANCER FEMALE 3 0.0002
844 HAIR TEXTURE ABNORMAL 2 0.0002
845 EXPIRED PRODUCT ADMINISTERED 4 0.0002
846 AGEUSIA 3 0.0002
847 SWOLLEN TONGUE 4 0.0002
848 MYOCARDIAL INFARCTION 25 0.0002
849 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0002
850 APPLICATION SITE PRURITUS 3 0.0002
851 PLATELET COUNT DECREASED 12 0.0002
852 ACNE 10 0.0002
853 DYSKINESIA 5 0.0002
854 PALPITATIONS 14 0.0002
855 ASTHMA 11 0.0002
856 EMOTIONAL DISORDER 4 0.0002
857 RESPIRATORY FAILURE 9 0.0002
858 BONE DENSITY DECREASED 4 0.0002
859 MUSCLE TIGHTNESS 2 0.0002
860 HEART RATE DECREASED 4 0.0002
861 DIPLOPIA 3 0.0002
862 LYMPHOCYTE COUNT DECREASED 2 0.0002
863 DYSPNOEA EXERTIONAL 4 0.0002
864 MENTAL DISORDER 5 0.0002
865 BLOOD PRESSURE ABNORMAL 2 0.0002
866 ACUTE RESPIRATORY FAILURE 2 0.0002
867 RHEUMATOID ARTHRITIS 12 0.0002
868 CEREBRAL INFARCTION 3 0.0002
869 LETHARGY 7 0.0002
870 FEMUR FRACTURE 4 0.0002
871 MANIA 2 0.0002
872 CARDIAC FAILURE 9 0.0002
873 MOOD SWINGS 4 0.0002
874 DRUG PRESCRIBING ERROR 3 0.0002
875 THROAT TIGHTNESS 3 0.0002
876 GASTRITIS 3 0.0002
877 ANOREXIA 2 0.0002
878 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
879 PULMONARY OEDEMA 5 0.0002
880 BRADYCARDIA 6 0.0002
881 EYE IRRITATION 5 0.0002
882 ADVERSE EVENT 10 0.0002
883 HEPATIC STEATOSIS 2 0.0002
884 VISUAL IMPAIRMENT 12 0.0002
885 LUNG DISORDER 5 0.0002
886 RENAL INJURY 4 0.0001
887 CIRCULATORY COLLAPSE 2 0.0001
888 DRUG TOXICITY 2 0.0001
889 PELVIC PAIN 2 0.0001
890 ATRIAL FIBRILLATION 10 0.0001
891 FOOT FRACTURE 2 0.0001
892 PRODUCT USE ISSUE 17 0.0001
893 COMA 5 0.0001
894 CARDIAC FAILURE CONGESTIVE 10 0.0001
895 ASCITES 3 0.0001
896 RENAL FAILURE ACUTE 6 0.0001
897 PRODUCT SUBSTITUTION ISSUE 6 0.0001
898 FEELING HOT 6 0.0001
899 DEVICE LEAKAGE 2 0.0001
900 HALLUCINATION 7 0.0001
901 BLOOD POTASSIUM DECREASED 3 0.0001
902 BONE DISORDER 2 0.0001
903 FLUID OVERLOAD 2 0.0001
904 SYNCOPE 10 0.0001
905 LUNG NEOPLASM MALIGNANT 4 0.0001
906 BLOOD GLUCOSE DECREASED 5 0.0001
907 FEELING JITTERY 2 0.0001
908 DEHYDRATION 13 0.0001
909 BODY TEMPERATURE INCREASED 2 0.0001
910 SEIZURE 9 0.0001
911 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
912 ANGIOEDEMA 4 0.0001
913 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
914 RESPIRATORY ARREST 3 0.0001
915 URINARY RETENTION 3 0.0001
916 ACUTE MYOCARDIAL INFARCTION 3 0.0001
917 TACHYCARDIA 8 0.0001
918 DRUG-INDUCED LIVER INJURY 2 0.0001
919 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
920 PANCREATITIS 5 0.0001
921 DRUG RESISTANCE 2 0.0001
922 OFF LABEL USE 53 0.0001
923 THERAPY CESSATION 4 0.0001
924 TREMOR 15 0.0001
925 PULMONARY EMBOLISM 9 0.0001
926 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
927 OXYGEN SATURATION DECREASED 4 0.0001
928 BLOOD COUNT ABNORMAL 2 0.0001
929 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
930 LIMB INJURY 2 0.0001
931 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
932 HYPOPHAGIA 2 0.0001
933 MULTI-ORGAN FAILURE 2 0.0001
934 DIABETIC KETOACIDOSIS 2 0.0001
935 PNEUMONIA ASPIRATION 2 0.0001
936 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
937 OSTEONECROSIS 3 0.0001
938 EXTRA DOSE ADMINISTERED 2 0.0001
939 DRUG HYPERSENSITIVITY 16 0.0001
940 MUCOSAL INFLAMMATION 2 0.0001
941 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
942 THROMBOCYTOPENIA 8 0.0001
943 INJURY 6 0.0001
944 WITHDRAWAL SYNDROME 3 0.0001
945 BLOOD GLUCOSE INCREASED 15 0.0001
946 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
947 EXPOSURE DURING PREGNANCY 4 0.0001
948 PANCREATIC CARCINOMA 2 0.0001
949 FEELING COLD 2 0.0001
950 LABORATORY TEST ABNORMAL 2 0.0001
951 OSTEONECROSIS OF JAW 2 0.0001
952 DRUG ADMINISTRATION ERROR 3 0.0001
953 HYPONATRAEMIA 4 0.0001
954 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
955 METABOLIC ACIDOSIS 2 0.0001
956 CARDIAC ARREST 6 0.0001
957 MENTAL STATUS CHANGES 2 0.0001
958 BONE PAIN 4 0.0001
959 NIGHT SWEATS 2 0.0001
960 EYE DISORDER 2 0.0001
961 COLITIS ULCERATIVE 2 0.0001
962 EYE PAIN 3 0.0001
963 CONVULSION 5 0.0001
964 ABNORMAL DREAMS 2 0.0001
965 ARRHYTHMIA 3 0.0001
966 SOMNOLENCE 12 0.0001
967 NEUTROPHIL COUNT DECREASED 2 0.0001
968 ACCIDENTAL OVERDOSE 2 0.0001
969 PLASMA CELL MYELOMA 2 0.0001
970 MALIGNANT NEOPLASM PROGRESSION 5 0.0001
971 UNDERDOSE 4 0.0001
972 DRUG INTERACTION 9 0.0001
973 FLUSHING 6 0.0001
974 NEUTROPENIA 6 0.0001
975 HYPERGLYCAEMIA 2 0.0001
976 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
977 BLADDER CANCER 3 0.0001
978 GYNAECOMASTIA 2 0.0001
979 DRUG WITHDRAWAL SYNDROME 4 0.0001
980 OVERDOSE 10 0.0001
981 OCULAR HYPERAEMIA 2 0.0001
982 DEATH 40 0.0001
983 INTENTIONAL PRODUCT USE ISSUE 3 0.0001
984 NO ADVERSE EVENT 6 0.0001
985 HYPOKALAEMIA 2 0.0001
986 ABNORMAL BEHAVIOUR 2 0.0001
987 ANAPHYLACTIC REACTION 2 0.0001
988 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
989 PRODUCT QUALITY ISSUE 6 0.0001
990 DISTURBANCE IN ATTENTION 2 0.0000
991 HOSPITALISATION 4 0.0000
992 DISEASE PROGRESSION 3 0.0000
993 AGITATION 2 0.0000
994 INTENTIONAL PRODUCT MISUSE 2 0.0000
995 DRUG DEPENDENCE 3 0.0000
996 COMPLETED SUICIDE 2 0.0000
997 TOXICITY TO VARIOUS AGENTS 3 0.0000